CCAD is associated with greater subjective olfactory dysfunction and a distinct allergic inflammatory profile. Tissue eosinophilia independently predicts postoperative corticosteroid use, while advanced disease and elevated blood eosinophils predict comorbid asthma. These findings support risk stratification and personalized postoperative management in CCAD.
Hsu et al. (2026) studied this question.